The changes approved by the Council of the Eurasian Economic Commission are aimed at improving the consistency of data in the register of medicines of the Eurasian Economic Union. According to the EEC press service, this will make the registration process more complex but will simplify procurement and the search for information about medicines.
What has changed in the medicine registration procedure
The main innovation is the requirement for applicants to indicate the international nonproprietary name of the active substance of the medicine. The common, grouping and chemical names will also have to be indicated.
What are the implications for the market and procurement
The decision taken by the EEC Council should ensure full consistency of information in the register of registered medicines of the EAEU. This, in turn, will help eliminate discrepancies when selecting medicines for procurement and will make it easier for citizens and pharmaceutical companies to find the information they need.
New requirements for applications
The EEC Council had previously approved a package of amendments concerning the rules for registration and expert review of medicines for medical use.
